Log In
BCIQ
Print this Print this
 

MER3101

  Manage Alerts
Collapse Summary General Information
Company Mercia Pharma Inc.
DescriptionSelf-antigen formulated with MAS-1 adjuvant
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentIND
Standard IndicationDiabetes
Indication DetailsTreat and prevent Type I diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today